Back to Search Start Over

Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass?

Authors :
Milone M
Di Minno MN
Leongito M
Maietta P
Bianco P
Taffuri C
Gaudioso D
Lupoli R
Savastano S
Milone F
Musella M
Source :
World journal of gastroenterology [World J Gastroenterol] 2013 Oct 21; Vol. 19 (39), pp. 6590-7.
Publication Year :
2013

Abstract

Aim: To investigate the weight loss and glycemic control status [blood glucose, hemoglobin A1c (HbA1c) and hypoglycaemic treatment].<br />Methods: The primary risk factor for type 2 diabetes is obesity, and 90% of all patients with type 2 diabetes are overweight or obese. Although a remarkable effect of bariatric surgery is the profound and durable resolution of type 2 diabetes clinical manifestations, little is known about the difference among various weight loss surgical procedures on diabetes remission. Data from patients referred during a 3-year period (from January 2009 to December 2011) to the University of Naples "Federico II" diagnosed with obesity and diabetes were retrieved from a prospective database. The patients were split into two groups according to the surgical intervention performed [sleeve gastrectomy (SG) and mini-gastric bypass (MGB)]. Weight loss and glycemic control status (blood glucose, HbA1c and hypoglycaemic treatment) were evaluated.<br />Results: A total of 53 subjects who underwent sleeve gastrectomy or mini-gastric bypass for obesity and diabetes were screened for the inclusion in this study. Of these, 4 subjects were excluded because of surgical complications, 7 subjects were omitted because young surgeons conducted the operations and 11 subjects were removed because of the lack of follow-up. Thirty-one obese patients were recruited for this study. A total of 15 subjects underwent SG (48.4%), and 16 underwent MGB (51.6%). After adjusting for various clinical and demographic characteristics in a multivariate logistic regression analysis, high hemoglobin A1c was determined to be a negative predictor of diabetes remission at 12 mo (OR = 0.366, 95%CI: 0.152-0.884). Using the same regression model, MGB showed a clear trend toward higher diabetes remission rates relative to SG (OR = 3.780, 95%CI: 0.961-14.872).<br />Conclusion: Although our results are encouraging regarding the effectiveness of mini-gastric bypass on diabetes remission, further studies are needed to provide definitive conclusions in selecting the ideal procedure for diabetes remission.

Details

Language :
English
ISSN :
2219-2840
Volume :
19
Issue :
39
Database :
MEDLINE
Journal :
World journal of gastroenterology
Publication Type :
Academic Journal
Accession number :
24151386
Full Text :
https://doi.org/10.3748/wjg.v19.i39.6590